Top Markets
#1 Useless Coin Useless Coin +39.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.96%
#3 0G 0G +36.39%
#4 StonkBroker StonkBroker +35.78%
#5 SAFEcoin SAFEcoin +29.23%
#6 Arbitrum Arbitrum +22.61%
#7 Zora Zora +20.61%
#8 Full Moon Full Moon +18.06%
#9 Notcoin Notcoin +18.04%
#10 Dogs Dogs +17.45%
Coin of the day
Useless Coin Useless Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Rangering i aksjer #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Aksjekurs
$12.63
Markedsverdi
$458.19M
Endring (1 dag)
-3.26%
Endring (1 år)
-
Land
US
Handel Evommune, Inc. (EVMN)

Kategori

Healthcare
Aksjeprishistorikk for Evommune, Inc. (EVMN)
Høyeste sluttskurs: $13.94 den 2026-08-01

Laveste sluttskurs: $19.25 den 2025-11-01
Aksjeprishistorikk for Evommune, Inc. fra 2025 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 9.44%
2025 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH